B7-H3 타깃 프로그램 | 바이오모아

Data Tier

ADC · Antibody · CGT를 FDA 승인, ORR·PASI·ACR·BCVA, 임상 등록 규모, Phase 3, 조회수 등 공개 데이터로 복합 점수화합니다. S–C 티어와 가점 요인은 규칙 기반(Data Tier)이며 LLM이 아닙니다.

B7-H3 타깃

Data Tier

프로그램 (23)

Anti-B7-H3 Chimeric Antigen Receptor T-Cell (CAR-T Cell, Anti-B7-H3 Chimeric Antigen Receptor T-Cell, Anti-B7-H3 Chimeric Antigen Receptor T-Cell (CAR-T Cell) Injection/TX103)

Intravenous (B7-H3CART Dose, B7-H3CART Dose (Intravenous))

B7-H3-CAR T Cells (B7-H3-CAR T Cells)

B7-H3.CD28Z.CART (B7-H3.CD28Z.CART)

fhB7H3.CAR-Ts (fhB7H3.CAR-Ts)

B7H3 specific CAR T cell with IL-7Ra signaling domain (B7H3 specific CAR T cell with IL-7Ra signaling domain)

B7H3 CAR-γδT cells (B7H3 CAR-γδT cells)

iC9-CAR.B7-H3 T Cell Therapy (iC9-CAR.B7-H3 T Cell Therapy)

Autologous B7-H3 CAR T (Autologous B7-H3 CAR T)

B7-H3 ADC (MHB088C for Injection, MHB088C for Injection (B7-H3 ADC))

B7-H3 CAR-T (B7-H3 CAR-T)

EGFR/B7H3 CAR-T (EGFR/B7H3 CAR-T)

iC9-CAR.B7-H3 T cell infusion (iC9-CAR.B7-H3 T cell infusion)

B7-H3CART (B7-H3CART)

SCRI-CARB7H3 (SCRI-CARB7H3, SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel)

T cell injection targeting B7-H3 chimeric antigen receptor (T cell injection targeting B7-H3 chimeric antigen receptor)

Intracerebroventricular injection of MT027 UCAR-T Cell targeting B7H3 (Intracerebroventricular injection of MT027 UCAR-T Cell targeting B7H3)

Dose level 3 (EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy, EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy (Dose level 3))

Dose level 2 (EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy, EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy (Dose level 2))

Dose level 1 (EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy, EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy (Dose level 1))

iC9-CAR.B7-H3 T cells (iC9-CAR.B7-H3 T cells)

CAR.B7-H3 (CAR.B7-H3)

Dose level 4 (EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy, EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy (Dose level 4))

B7-H3 타깃

Data Tier

프로그램 (23)

Anti-B7-H3 Chimeric Antigen Receptor T-Cell (CAR-T Cell, Anti-B7-H3 Chimeric Antigen Receptor T-Cell, Anti-B7-H3 Chimeric Antigen Receptor T-Cell (CAR-T Cell) Injection/TX103)

Intravenous (B7-H3CART Dose, B7-H3CART Dose (Intravenous))

B7-H3-CAR T Cells (B7-H3-CAR T Cells)

B7-H3.CD28Z.CART (B7-H3.CD28Z.CART)

fhB7H3.CAR-Ts (fhB7H3.CAR-Ts)

B7H3 specific CAR T cell with IL-7Ra signaling domain (B7H3 specific CAR T cell with IL-7Ra signaling domain)

B7H3 CAR-γδT cells (B7H3 CAR-γδT cells)

iC9-CAR.B7-H3 T Cell Therapy (iC9-CAR.B7-H3 T Cell Therapy)

Autologous B7-H3 CAR T (Autologous B7-H3 CAR T)

B7-H3 ADC (MHB088C for Injection, MHB088C for Injection (B7-H3 ADC))

B7-H3 CAR-T (B7-H3 CAR-T)

EGFR/B7H3 CAR-T (EGFR/B7H3 CAR-T)

iC9-CAR.B7-H3 T cell infusion (iC9-CAR.B7-H3 T cell infusion)

B7-H3CART (B7-H3CART)

SCRI-CARB7H3 (SCRI-CARB7H3, SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel)

T cell injection targeting B7-H3 chimeric antigen receptor (T cell injection targeting B7-H3 chimeric antigen receptor)

Intracerebroventricular injection of MT027 UCAR-T Cell targeting B7H3 (Intracerebroventricular injection of MT027 UCAR-T Cell targeting B7H3)

Dose level 3 (EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy, EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy (Dose level 3))

Dose level 2 (EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy, EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy (Dose level 2))

Dose level 1 (EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy, EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy (Dose level 1))

iC9-CAR.B7-H3 T cells (iC9-CAR.B7-H3 T cells)

CAR.B7-H3 (CAR.B7-H3)

Dose level 4 (EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy, EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy (Dose level 4))

B7-H3 타깃

Data Tier

프로그램 (23)

Anti-B7-H3 Chimeric Antigen Receptor T-Cell (CAR-T Cell, Anti-B7-H3 Chimeric Antigen Receptor T-Cell, Anti-B7-H3 Chimeric Antigen Receptor T-Cell (CAR-T Cell) Injection/TX103)

Intravenous (B7-H3CART Dose, B7-H3CART Dose (Intravenous))

B7-H3-CAR T Cells (B7-H3-CAR T Cells)

B7-H3.CD28Z.CART (B7-H3.CD28Z.CART)

fhB7H3.CAR-Ts (fhB7H3.CAR-Ts)

B7H3 specific CAR T cell with IL-7Ra signaling domain (B7H3 specific CAR T cell with IL-7Ra signaling domain)

B7H3 CAR-γδT cells (B7H3 CAR-γδT cells)

iC9-CAR.B7-H3 T Cell Therapy (iC9-CAR.B7-H3 T Cell Therapy)

Autologous B7-H3 CAR T (Autologous B7-H3 CAR T)

B7-H3 ADC (MHB088C for Injection, MHB088C for Injection (B7-H3 ADC))

B7-H3 CAR-T (B7-H3 CAR-T)

EGFR/B7H3 CAR-T (EGFR/B7H3 CAR-T)

iC9-CAR.B7-H3 T cell infusion (iC9-CAR.B7-H3 T cell infusion)

B7-H3CART (B7-H3CART)

SCRI-CARB7H3 (SCRI-CARB7H3, SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel)

T cell injection targeting B7-H3 chimeric antigen receptor (T cell injection targeting B7-H3 chimeric antigen receptor)

Intracerebroventricular injection of MT027 UCAR-T Cell targeting B7H3 (Intracerebroventricular injection of MT027 UCAR-T Cell targeting B7H3)

Dose level 3 (EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy, EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy (Dose level 3))

Dose level 2 (EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy, EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy (Dose level 2))

Dose level 1 (EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy, EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy (Dose level 1))

iC9-CAR.B7-H3 T cells (iC9-CAR.B7-H3 T cells)

CAR.B7-H3 (CAR.B7-H3)

Dose level 4 (EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy, EPC-003 Fully Human Anti-B7H3/IL13Ra2 Armored CAR-T Cell Therapy (Dose level 4))